These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
61 related articles for article (PubMed ID: 8639050)
1. Immunohistochemical markers of prolonged survival in small cell carcinoma of the lung. An immunohistochemical study. Sloman A; D'Amico F; Yousem SA Arch Pathol Lab Med; 1996 May; 120(5):465-72. PubMed ID: 8639050 [TBL] [Abstract][Full Text] [Related]
2. P53 expression in small cell carcinoma of the urinary bladder: biological and prognostic implications. Wang X; Jones TD; Maclennan GT; Yang XJ; Lopez-Beltran A; Eble JN; Koch MO; Lin H; Baldridge LA; Tretiakova M; Cheng L Anticancer Res; 2005; 25(3B):2001-4. PubMed ID: 16158936 [TBL] [Abstract][Full Text] [Related]
3. [Prognostic value of expression of FASE, HER-2/neu, bcl-2 and p53 in stage I non-small cell lung cancer]. Wang Y; Zhang XR; Fu J; Tan W; Zhang W Zhonghua Zhong Liu Za Zhi; 2004 Jun; 26(6):369-72. PubMed ID: 15312350 [TBL] [Abstract][Full Text] [Related]
4. The prognostic significance of neuroendocrine markers and carcinoembryonic antigen in patients with resected stage I and II non-small cell lung cancer. Graziano SL; Tatum AH; Newman NB; Oler A; Kohman LJ; Veit LJ; Gamble GP; Coleman MJ; Barmada S; O'Lear S Cancer Res; 1994 Jun; 54(11):2908-13. PubMed ID: 8187076 [TBL] [Abstract][Full Text] [Related]
5. Bcl-2, p53, CD44, and CD44v6 isoform expression in neuroendocrine tumors of the lung. Coppola D; Clarke M; Landreneau R; Weyant RJ; Cooper D; Yousem SA Mod Pathol; 1996 May; 9(5):484-90. PubMed ID: 8733762 [TBL] [Abstract][Full Text] [Related]
6. Laminin and cathepsin B as prognostic factors in stage I non-small cell lung cancer: are they useful? Mori M; Kohli A; Baker SP; Savas L; Fraire AE Mod Pathol; 1997 Jun; 10(6):572-7. PubMed ID: 9195574 [TBL] [Abstract][Full Text] [Related]
7. Study of pretreatment serum levels of HER-2/neu oncoprotein as a prognostic and predictive factor in patients with advanced nonsmall cell lung carcinoma. Ardizzoni A; Cafferata MA; Paganuzzi M; Filiberti R; Marroni P; Neri M; Fontana V; Nicoló G; Perdelli L; Stampino CG; Rosso R; Puntoni R Cancer; 2001 Oct; 92(7):1896-904. PubMed ID: 11745263 [TBL] [Abstract][Full Text] [Related]
9. An immunohistochemical and prognostic evaluation of cathepsin D expression in 105 bladder carcinomas. Dickinson AJ; Fox SB; Newcomb PV; Persad RA; Sibley GN; Harris AL J Urol; 1995 Jul; 154(1):237-41. PubMed ID: 7776437 [TBL] [Abstract][Full Text] [Related]
10. Mental state as a possible independent prognostic variable for survival in patients with advanced lung carcinoma. Nakahara Y; Mochizuki Y; Miyamoto Y; Tanaka A; Kawamura T; Sasaki S; Nakahara Y; Katsura Y Cancer; 2002 Jun; 94(11):3006-15. PubMed ID: 12115391 [TBL] [Abstract][Full Text] [Related]
11. The pathology of low-grade adenosquamous carcinoma of the breast. An immunohistochemical study. Drudis T; Arroyo C; Van Hoeven K; Cordon-Cardo C; Rosen PP Pathol Annu; 1994; 29 ( Pt 2)():181-97. PubMed ID: 7936747 [TBL] [Abstract][Full Text] [Related]
12. Prognostic implications of calbindin-D28k expression in lung cancer: analysis of 452 cases. Castro CY; Stephenson M; Gondo MM; Medeiros LJ; Cagle PT Mod Pathol; 2000 Jul; 13(7):808-13. PubMed ID: 10912942 [TBL] [Abstract][Full Text] [Related]
13. Identification of immunohistochemical prognostic markers for survival after resection of pulmonary metastases from colorectal carcinoma. Pfannschmidt J; Bade S; Hoheisel J; Muley T; Dienemann H; Herpel E Thorac Cardiovasc Surg; 2009 Oct; 57(7):403-8. PubMed ID: 19795327 [TBL] [Abstract][Full Text] [Related]
14. Chemotherapy for small cell lung carcinoma: the Greenlane Hospital experience 1993-1995. Lee YC; McCrystal MR; Christmas TI N Z Med J; 1998 Nov; 111(1078):451-2, 453-4. PubMed ID: 9891564 [TBL] [Abstract][Full Text] [Related]
15. Metallothionein expression in patients with small cell carcinoma of the lung: correlation with other molecular markers and clinical outcome. Joseph MG; Banerjee D; Kocha W; Feld R; Stitt LW; Cherian MG Cancer; 2001 Aug; 92(4):836-42. PubMed ID: 11550155 [TBL] [Abstract][Full Text] [Related]
16. Clinical significance of vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 in patients with nonsmall cell lung carcinoma. Arinaga M; Noguchi T; Takeno S; Chujo M; Miura T; Uchida Y Cancer; 2003 Jan; 97(2):457-64. PubMed ID: 12518370 [TBL] [Abstract][Full Text] [Related]
17. High prevalence of bcl-2 oncoprotein expression in small cell lung cancer. Higashiyama M; Doi O; Kodama K; Yokouchi H; Tateishi R Anticancer Res; 1995; 15(2):503-5. PubMed ID: 7763030 [TBL] [Abstract][Full Text] [Related]
18. Prognostic value of FHIT, CTNNB1, and MUC1 expression in non-small cell lung cancer. Woenckhaus M; Merk J; Stoehr R; Schaeper F; Gaumann A; Wiebe K; Hartmann A; Hofstaedter F; Dietmaier W Hum Pathol; 2008 Jan; 39(1):126-36. PubMed ID: 17949785 [TBL] [Abstract][Full Text] [Related]
19. Tumor expression of S100A6 correlates with survival of patients with stage I non-small-cell lung cancer. De Petris L; Orre LM; Kanter L; Pernemalm M; Koyi H; Lewensohn R; Lehtiö J Lung Cancer; 2009 Mar; 63(3):410-7. PubMed ID: 18620780 [TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of the tumor suppressor gene maspin in non-small cell lung cancer. Hirai K; Koizumi K; Haraguchi S; Hirata T; Mikami I; Fukushima M; Yamagishi S; Kawashima T; Okada D; Shimizu K; Kawamoto M Ann Thorac Surg; 2005 Jan; 79(1):248-53. PubMed ID: 15620951 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]